A new approach for safe drug delivery by drug-coated balloons — WOMBAT® IIb




Background


Drug-coated balloons transfer only a small part of the drug to the tissue. Most of the drug is lost into the bloodstream probably during inflation. To overcome this problem, we wrapped commercial PTCA balloons with laser-structured polyisoprene tubes (WOMBAT® Drug Reservoir Technology).




Methods and results


The polyisoprene tubes contain reservoirs which close when the balloon is relaxed and open when the balloon is expanded. Using paclitaxel+excipients as a model drug, the loading of the WOMBAT® IIb revealed that about 40% up to 70% of the drug is located in the reservoirs. Removal of the remaining part on the surface (not in the reservoirs) was done either mechanically by multiple sheath passages or by washing the (relaxed) balloons with ethanol-water mixtures. The efficiency to remove the drug from the surface and not from the reservoirs was tested by microscopic inspection and drug quantitation. Drug vessel uptake studies of WOMBAT® IIb (porcine model) revealed that the drug transfer from the reservoirs has a comparable efficacy as that of non-laser-structured polyisoprene-wrapped balloons. Hence, WOMBAT® IIb allows a safe and efficient drug transfer with minimal surface coating.


WOMBAT® is a trademark of AVIDAL Vascular GmbH, Germany, describing a new class of interventional products for intraluminal drug application: W raps over M edical BA lloons T echnology.


Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on A new approach for safe drug delivery by drug-coated balloons — WOMBAT® IIb

Full access? Get Clinical Tree

Get Clinical Tree app for offline access